Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
基本信息
- 批准号:8448648
- 负责人:
- 金额:$ 35.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-01 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adrenal GlandsAdverse effectsAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAntigensApoptosisAsthmaBiological ModelsBone MarrowCD4 Positive T LymphocytesCell LineCell modelCellsDataDendritic CellsDevelopmentDiseaseDrug TargetingDrug or chemical Tissue DistributionEukaryotic Initiation FactorsGene ExpressionGene Expression RegulationGlucocorticoid ReceptorGlucocorticoid-induced apoptosisGlucocorticoidsGoalsHelper-Inducer T-LymphocyteImmuneImmunityImmunosuppressive AgentsIndividualInflammationInflammatoryInflammatory ResponseInformaticsLigandsLipopolysaccharidesLungMediastinal lymph node groupMediatingMessenger RNAMetabolic syndromeModelingMusOdds RatioOsteoblastsOsteoporosisPatternPharmaceutical PreparationsPituitary GlandPlayProductionProtein IsoformsRegulationRegulatory T-LymphocyteResistanceRoleScanningSentinelStagingStimulusT-LymphocyteT-Lymphocyte SubsetsTestingToll-like receptorsTranslationsWorkabstractingairborne allergenbasecell typecytokinedesignimprovedkillingspathogenrespiratoryrisk benefit ratioselective expressionstable cell linetherapy developmenttranslation factoruptake
项目摘要
Abstract: Glucocorticoids are indispensable in the treatment of asthma and other inflammatory diseases
although side effects such as hypothalamo-pituitary-adrenal suppression, metabolic syndrome, and
osteoporosis limit their use. Our goal is to understand the mechanisms by which the glucocorticoid receptor
(GR) mediates cell-specific functions, as this information may be useful in the development of treatments for
asthma with improved efficacy/risk ratios. We have recently discovered that the GR has eight distinct
translational isoforms expressed variably in a wide range of cell types. These GR isoforms have profoundly
different effects on gene expression. We hypothesize that selective GR translational isoforms mediate
distinct sensitivities to glucocorticoid-induced apoptosis and regulate cell-specific inflammatory
responses in T cell and dendritic cell subsets that are crucial in asthma. We propose that inflammatory
stimuli selectively regulate GR isoforms via translational mechanisms. To test these hypotheses, we will
examine primary T cells and dendritic cells obtained from a murine asthma model, cell lines expressing
individual GR isoforms, and bone marrow-derived dendritic cells. Studies in Aim 1 will determine in a murine
asthma model the identity and function of GR translational isoforms in helper T cells that are sensitive and
regulatory T cells (Tregs) that are resistant to glucocorticoid-induced apoptosis. Our preliminary data indicate
that helper T cells express predominantly the proapoptotic GR-A isoform whereas Tregs have predominantly
the GR-D isoforms that are incapable of inducing apoptosis in osteoblast and T cell model systems. We will
determine the role of selective GR isoforms in T cell subset-specific functions and glucocorticoid sensitivities.
Studies in Aim 2 will determine the identity and function of GR translational isoforms in immature and mature
dendritic cells that also have distinct sensitivities to glucocorticoid-induced apoptosis. Our preliminary data
indicate that immature dendritic cells switch from the GR-D isoforms to expressing the GR-A isoform after
maturation. The role of GR isoforms in distinct glucocorticoid sensitivities of immature (insensitive) and mature
(sensitive) dendritic cells and in maturational-stage specific functions will be determined. Studies in Aim 3 will
determine the role of translation machinery in regulating the expression of selective GR isoforms. Our previous
studies indicate that the GR translational isoforms are produced from a single species of mRNA via ribosomal
leaky scanning and ribosomal shunting. Based on our preliminary results, we will focus on the role of
eukaryotic initiation factors in selective expression of GR isoforms. These studies will improve our
understanding of the cell-specific actions of GR translational isoforms in asthma. Selective GR
isoforms are anticipated to mediate cell-specific sensitivities to glucocorticoids and regulate cell-
specific functions. In addition, these studies may provide a basis for the development of anti-
inflammatory drugs targeting or altering the expression of selective GR isoforms.
摘要:糖皮质激素在哮喘等炎症性疾病的治疗中是不可缺少的
虽然副作用,如下丘脑-垂体-肾上腺抑制,代谢综合征,
骨质疏松症限制了它们的使用。我们的目标是了解糖皮质激素受体
(GR)介导细胞特异性功能,因为这些信息可能有助于开发治疗
哮喘,改善疗效/风险比。我们最近发现GR有八个不同的
翻译异构体在广泛的细胞类型中表达。这些GR亚型具有深刻的
对基因表达的不同影响。我们假设选择性GR翻译异构体介导
对糖皮质激素诱导的细胞凋亡和调节细胞特异性炎症反应的不同敏感性
T细胞和树突状细胞亚群的反应在哮喘中至关重要。我们认为,
刺激通过翻译机制选择性调节GR亚型。为了验证这些假设,我们将
检测从小鼠哮喘模型获得的原代T细胞和树突状细胞,表达
单个GR同种型和骨髓来源的树突状细胞。目标1中的研究将在小鼠中确定
哮喘模型GR翻译亚型的身份和功能的辅助T细胞,是敏感的,
调节性T细胞(Tcells)对糖皮质激素诱导的细胞凋亡具有抗性。我们的初步数据显示
辅助性T细胞主要表达促凋亡GR-A同种型,而T细胞主要表达促凋亡GR-A同种型,
GR-D同种型不能在成骨细胞和T细胞模型系统中诱导凋亡。我们将
确定选择性GR亚型在T细胞亚群特异性功能和糖皮质激素敏感性中的作用。
目标2中的研究将确定GR翻译异构体在未成熟和成熟细胞中的身份和功能。
树突状细胞也对糖皮质激素诱导的凋亡具有不同的敏感性。我们的初步数据
表明未成熟树突状细胞从GR-D同种型转变为表达GR-A同种型,
成熟糖皮质激素受体亚型在未成熟(不敏感)和成熟的糖皮质激素敏感性中的作用
(敏感的)树突细胞和成熟阶段的特异性功能将被确定。目标3中的研究将
确定翻译机制在调节选择性GR亚型表达中的作用。我们以前的
研究表明,GR翻译同种型是由单一种类的mRNA通过核糖体介导产生的。
泄漏扫描和核糖体分流。根据我们的初步结果,我们将重点讨论
真核生物起始因子在GR亚型选择性表达中的作用。这些研究将改善我们的
了解哮喘中GR翻译亚型的细胞特异性作用。选择性GR
预期同种型介导细胞对糖皮质激素的特异性敏感性,并调节细胞对糖皮质激素的敏感性。
具体功能。此外,这些研究可能为开发抗-
靶向或改变选择性GR同种型表达的炎性药物。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Molecular mechanisms regulating glucocorticoid sensitivity and resistance.
- DOI:10.1016/j.mce.2008.10.001
- 发表时间:2009-03-05
- 期刊:
- 影响因子:4.1
- 作者:Gross KL;Lu NZ;Cidlowski JA
- 通讯作者:Cidlowski JA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NICK LU其他文献
NICK LU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NICK LU', 18)}}的其他基金
Glucocorticoid induced G-CSF in lung inflammation
糖皮质激素诱导 G-CSF 治疗肺部炎症
- 批准号:
9336499 - 财政年份:2016
- 资助金额:
$ 35.58万 - 项目类别:
Glucocorticoids and glucocorticoid receptor translational isoforms
糖皮质激素和糖皮质激素受体翻译亚型
- 批准号:
8773073 - 财政年份:2014
- 资助金额:
$ 35.58万 - 项目类别:
Glucocorticoids and glucocorticoid receptor translational isoforms
糖皮质激素和糖皮质激素受体翻译亚型
- 批准号:
8890110 - 财政年份:2014
- 资助金额:
$ 35.58万 - 项目类别:
Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
- 批准号:
8240049 - 财政年份:2009
- 资助金额:
$ 35.58万 - 项目类别:
Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
- 批准号:
7838659 - 财政年份:2009
- 资助金额:
$ 35.58万 - 项目类别:
Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
- 批准号:
7786958 - 财政年份:2009
- 资助金额:
$ 35.58万 - 项目类别:
Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
- 批准号:
8477836 - 财政年份:2009
- 资助金额:
$ 35.58万 - 项目类别:
Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
- 批准号:
7663499 - 财政年份:2009
- 资助金额:
$ 35.58万 - 项目类别:
Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
- 批准号:
8051828 - 财政年份:2009
- 资助金额:
$ 35.58万 - 项目类别:
Environment and Obesity: preventing stress hormone-induced obesity with genistein
环境与肥胖:用金雀异黄素预防应激激素引起的肥胖
- 批准号:
7090949 - 财政年份:2007
- 资助金额:
$ 35.58万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 35.58万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 35.58万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 35.58万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 35.58万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 35.58万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 35.58万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 35.58万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 35.58万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 35.58万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 35.58万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




